Takeda Pharmaceutical Co. Ltd. - Return On Equity

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.

The item "Return-On-Equity" stands at 0.4667 percent as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Return On Equity" stands at 0.4667 Percent. This represents a decrease of -1.48 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -3.57 percentage points compared to the value the year prior.
The 1 year change in percentage points is -3.57.
The 3 year change in percentage points is -3.08.

The Serie's long term average value is 3.05 percent. It's latest available value, on 09/30/2025, is 2.58 percentage points lower, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0.
The Serie's change in percentage points from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -4.49.